The dose-response relationship in the high/medium dose range can be linear, bell-shaped, or plateau shaped due to a balance between cell kill and repopulation. Organ specific survival probabilities as well as the probability for mutation and spontaneous mutation rate can be approximated in a linear-quadratic form. When analyzing high or medium dose areas one has to consider that organs typically receive inhomogeneous dose distributions. Other than for low dose risk assessments, average dose values are not applicable. We applied the 'organ equivalent dose' (OED). For low doses, the OED represents the average organ dose while at medium/high doses the OED takes into account the impact of cell killing. The underlying dose-response function is linear-exponential taking into account cell-killing effects by an exponential function that depends on the dose and an organ-specific cell sterilization factor. The excess absolute risk (EAR), as a function of dose as well as the individual's gender, attained age and age at exposure can be defined as a product of OED and the initial slope based on a risk factor based on low-dose risk models (Schneider et al. Int J Radiat Oncol Biol Phys 2007 ;68:892). Results and Discussion:
total energy deposited (in Joules) in the patient (integral dose). For the optic glioma cases there is an advantage in LAR of 3-field proton therapy compared to IMRT by a factor of ~2 for the 4-year old and a factor of ~2.5 for the 14-year old. There is not a one-to-one correlation between the integral dose and the risk because the distribution of the dose plays a role as well. This is seen quite nicely for the Ewing's sarcoma cases where the integral dose difference between IMRT and proton therapy is a factor of ~2 but IMRT does show a higher cancer risk by a factor of 3-11. Distributing the dose to a larger volume results in a slightly higher risk due to a nonlinear dose-response. The risk difference comparing a 4-field to a 3-field plan can be in the order of 15%-40%. This has to be balanced against other side effects, e.g. while using fewer fields might irradiate less brain tissue and reduce the risk for a second malignancy later in life, it causes the irradiation of a smaller volume with a higher dose, which could have severe consequences for cognitive development.
